Serum decorin and biglycan levels as predictive biomarkers for lung fibrosis severity and mortality risk in COVID-19 patients

Serum decorin and biglycan levels as predictive biomarkers for lung fibrosis severity and mortality risk in COVID-19 patients

IntroductionIndividuals experiencing severe symptoms of COVID-19 are at the greatest risk of developing post-COVID lung fibrosis, which significantly impacts long-term health outcomes. This study aims to investigate the predictive potential of serum biomarkers, specifically decorin and biglycan, in...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaaf Ahmad, Kaleem Maqsood, Farwa Liaqat, Nabila Roohi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
COVID-19
decorin
biglycan
proteoglycan
lung fibrosis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1463433/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items